International Journal of Clinical Research

Objective: To explore the effect of ligustrazine injection on clinical efficacy and neurological improvement in the treatment of cerebral infarction. Methods: The subjects were 80 patients with cerebral infarction treated in hospital from 2021.01 to 2023.01, and were divided into control group and observation group by random envelope method, with 40 cases in each group. The control group was treated with ozagre, and the observation group was treated with ligustrazine injection. The clinical efficacy and clinical indicators of the two groups were compared. Results: The total therapeutic efficiency of the observation group was higher than that of the control group (P<0.05); The neurological deficit score, plaque area, and plaque thickness in the observation group were lower than those in the control group (P<0.05); The level of hemorheology in the observation group was lower than that in the control group (P<0.05). Conclusion: Adjuvant therapy with ligustrazine injection can improve the neurological function of patients, and also reduce the area and thickness of plaques, which is conducive to improving the curative effect and suitable for popularization and reference.

Cerebral infarction; Ligustrazine injection; Efficacy; Neurological function